These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 20332565)

  • 21. Preparation and in vitro/in vivo evaluation of nano-sized crystals for dissolution rate enhancement of ucb-35440-3, a highly dosed poorly water-soluble weak base.
    Hecq J; Deleers M; Fanara D; Vranckx H; Boulanger P; Le Lamer S; Amighi K
    Eur J Pharm Biopharm; 2006 Nov; 64(3):360-8. PubMed ID: 16846725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Micronization of silybin by the emulsion solvent diffusion method.
    Zhang ZB; Shen ZG; Wang JX; Zhang HX; Zhao H; Chen JF; Yun J
    Int J Pharm; 2009 Jul; 376(1-2):116-22. PubMed ID: 19409464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanoprecipitation with sonication for enhancement of oral bioavailability of furosemide.
    Sahu BP; Das MK
    Acta Pol Pharm; 2014; 71(1):129-37. PubMed ID: 24779201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation of azithromycin nanosuspensions by reactive precipitation method.
    Hou CD; Wang JX; Le Y; Zou HK; Zhao H
    Drug Dev Ind Pharm; 2012 Jul; 38(7):848-54. PubMed ID: 22092042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of ascorbyl palmitate nanocrystals applying the nanosuspension technology.
    Teeranachaideekul V; Junyaprasert VB; Souto EB; Müller RH
    Int J Pharm; 2008 Apr; 354(1-2):227-34. PubMed ID: 18242898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dexamethasone-loaded nanoparticle-coated microparticles: correlation between in vitro drug release and drug transport across Caco-2 cell monolayers.
    Beck RC; Pohlmann AR; Hoffmeister C; Gallas MR; Collnot E; Schaefer UF; Guterres SS; Lehr CM
    Eur J Pharm Biopharm; 2007 Aug; 67(1):18-30. PubMed ID: 17317124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhance the dissolution rate and oral bioavailability of pranlukast by preparing nanosuspensions with high-pressure homogenizing method.
    Wang L; Hao Y; Liu N; Ma M; Yin Z; Zhang X
    Drug Dev Ind Pharm; 2012 Nov; 38(11):1381-9. PubMed ID: 22300415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation, characterization, stability and in vitro-in vivo evaluation of pellet-layered Simvastatin nanosuspensions.
    Luo Y; Xu L; Tao X; Xu M; Feng J; Tang X
    Drug Dev Ind Pharm; 2013 Jul; 39(7):936-46. PubMed ID: 23046250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine.
    Hecq J; Deleers M; Fanara D; Vranckx H; Amighi K
    Int J Pharm; 2005 Aug; 299(1-2):167-77. PubMed ID: 15996838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on pharmacokinetics and tissue distribution of bifendate nanosuspensions for intravenous delivery.
    Liu Y; Zhang D; Duan C; Jia L; Xie P; Zheng D; Wang F; Liu G; Hao L; Zhang X; Zhang Q
    J Microencapsul; 2012; 29(2):194-203. PubMed ID: 22172025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of drug physicochemical properties on absorption of water insoluble drug nanosuspensions.
    Li W; Quan P; Zhang Y; Cheng J; Liu J; Cun D; Xiang R; Fang L
    Int J Pharm; 2014 Jan; 460(1-2):13-23. PubMed ID: 24184036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral bioavailability of silymarin formulated as a novel 3-day delivery system based on porous silica nanoparticles.
    Cao X; Fu M; Wang L; Liu H; Deng W; Qu R; Su W; Wei Y; Xu X; Yu J
    Acta Biomater; 2012 Jul; 8(6):2104-12. PubMed ID: 22343518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fabrication and in vitro/in vivo evaluation of amorphous andrographolide nanosuspensions stabilized by d-α-tocopheryl polyethylene glycol 1000 succinate/sodium lauryl sulfate.
    Qiao H; Chen L; Rui T; Wang J; Chen T; Fu T; Li J; Di L
    Int J Nanomedicine; 2017; 12():1033-1046. PubMed ID: 28223797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system.
    Wu W; Wang Y; Que L
    Eur J Pharm Biopharm; 2006 Jul; 63(3):288-94. PubMed ID: 16527467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dermal flurbiprofen nanosuspensions: Optimization with design of experiment approach and in vitro evaluation.
    Oktay AN; Karakucuk A; Ilbasmis-Tamer S; Celebi N
    Eur J Pharm Sci; 2018 Sep; 122():254-263. PubMed ID: 29981401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.
    Attama AA; Schicke BC; Paepenmüller T; Müller-Goymann CC
    Eur J Pharm Biopharm; 2007 Aug; 67(1):48-57. PubMed ID: 17276663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phytosome-nanosuspensions for silybin-phospholipid complex with increased bioavailability and hepatoprotection efficacy.
    Chi C; Zhang C; Liu Y; Nie H; Zhou J; Ding Y
    Eur J Pharm Sci; 2020 Mar; 144():105212. PubMed ID: 31923602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a chemically stable 10-hydroxycamptothecin nanosuspensions.
    Pu X; Sun J; Wang Y; Wang Y; Liu X; Zhang P; Tang X; Pan W; Han J; He Z
    Int J Pharm; 2009 Sep; 379(1):167-73. PubMed ID: 19505545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Preparation of silymarin proliposomes and its pharmacokinetics in rats].
    Xiao YY; Song YM; Chen ZP; Ping QN
    Yao Xue Xue Bao; 2005 Aug; 40(8):758-63. PubMed ID: 16268514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced bioavailability after oral and pulmonary administration of baicalein nanocrystal.
    Zhang J; Lv H; Jiang K; Gao Y
    Int J Pharm; 2011 Nov; 420(1):180-8. PubMed ID: 21878378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.